GT
MDXG icon

Glenmede Trust’s MiMedx Group MDXG Stock Holding History

Glenmede Trust’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-41
Closed – – 2550
2020
Q1 		$0 Hold
41
– – ﹤0.01% 3041
2019
Q4 		$0 Hold
41
– – ﹤0.01% 3085
2019
Q3 		$0 Hold
41
– – ﹤0.01% 3076
2019
Q2 		$0 Sell
41
-237
-85% – ﹤0.01% 3132
2019
Q1 		$0 Hold
278
– – ﹤0.01% 3131
2018
Q4 		$0 Buy
+278
New +$1.54K ﹤0.01% 3060

Other funds holding MDXG

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
TIM
Thompson Investment Management Madison, Wisconsin $872M AUM 35.59% 1-Year Est. Return
WMC
Westwood Management Corporation Chicago, Illinois $270M AUM 54.59% 1-Year Est. Return
PAM
Pegasus Asset Management Montebello, New York $313M AUM 24.74% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
NCM
Next Capital Management New York $330M AUM 11.54% 1-Year Est. Return
CCB
Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

Glenmede Trust's MDXG Position: Q2 2020 in Review

Glenmede Trust sold out of MiMedx Group (MDXG) in Q2 2020, closing a stake of 41 shares.

Glenmede Trust first reported a position in MDXG in Q4 2018 and held it in 6 quarters. The position peaked at $0 in Q1 2020. 20 funds tracked by Wall St. Rank hold MDXG as of Q2 2020.

  • Glenmede Trust reported no remaining MiMedx Group position as of Q2 2020 after selling out during the quarter.
  • Glenmede Trust sold 41 MiMedx Group shares in Q2 2020.
  • Glenmede Trust first reported a position in MiMedx Group in Q4 2018 and held it in 6 quarters.
  • Glenmede Trust's MiMedx Group position peaked at $0 in Q1 2020.
  • 20 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2020.

Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.